EIR BioReliance Sep 2004

Lynette Salisbury FDA$595.00 - Available Now

FDA investigators audited the BioReliance - Rockville, MD, United States facility and issued inspectional observation (via FDA 483) on 23 Sep 2004.

Product details

  • Category:
  • Inspection end: 23 Sep 2004
  • Location: Rockville, United States
  • FEI: 1122041
Add To Cart